The main prescription for COVID-19 is Paxlovid, an oral antiviral pill taken twice a day for five days. It’s the first-choice treatment for people with mild to moderate symptoms who are at higher risk of getting seriously ill. Two other antivirals, remdesivir and molnupiravir, serve as backups when Paxlovid isn’t an option. Most people with COVID-19, though, recover at home with nothing more than over-the-counter fever and pain relievers.
Who Qualifies for Prescription Treatment
Antiviral medications for COVID-19 are not prescribed to everyone who tests positive. They’re reserved for people with mild or moderate illness who have at least one risk factor for developing severe disease. That includes conditions like obesity, diabetes, heart disease, chronic lung disease, immunocompromising conditions, and being over 65. The goal is to prevent a manageable infection from progressing to hospitalization or death.
Timing is critical. Treatment needs to start as soon as possible and within five to seven days of when symptoms began. The earlier you start, the better antivirals work. If you test positive and have any chronic health condition, contact your doctor or a telehealth provider quickly rather than waiting to see if you get worse.
Paxlovid: The First-Choice Antiviral
Paxlovid (nirmatrelvir/ritonavir) is a combination pill that works by blocking the enzyme the virus needs to replicate inside your cells. It’s approved for adults and for adolescents 12 and older who weigh at least 88 pounds. You take it twice daily for five days, starting within five days of your first symptoms.
The catch with Paxlovid is that it interacts with a long list of other medications. One of its components, ritonavir, affects how your liver processes many common drugs. If you take certain heart rhythm medications, seizure medications, specific cholesterol-lowering statins like lovastatin or simvastatin, or even the herbal supplement St. John’s Wort, Paxlovid may be unsafe or require your doctor to temporarily pause those medications. People on hormonal birth control containing ethinyl estradiol should use a backup contraceptive method during treatment and for one menstrual cycle afterward.
Paxlovid is also not recommended for people with severe kidney or liver disease. If you have moderate kidney impairment, your doctor can prescribe a reduced dose.
COVID Rebound After Paxlovid
Some people feel better after finishing Paxlovid, then experience a return of symptoms three to seven days later. This “rebound” got a lot of attention early on, but the numbers are more reassuring than the headlines suggested. A large observational study found rebound occurred in about 7% of Paxlovid-treated patients, compared to roughly 5% of people who received no treatment at all. Other studies have put the rebound rate slightly higher, around 10 to 14% among treated patients. Rebound illness is typically mild and resolves on its own, with most people testing negative by about 16 days after their original diagnosis.
Remdesivir: The IV Alternative
If you can’t take Paxlovid because of drug interactions or other reasons, remdesivir (Veklury) is the second-choice option. Unlike Paxlovid, it’s given intravenously, which means you’ll need to visit an infusion center or clinic for three consecutive days. Treatment must start within seven days of symptom onset.
Remdesivir is the only antiviral option available for very young patients, approved down to infants older than 28 days who weigh more than about 7 pounds. For adults, it’s effective but less convenient than a pill you take at home, which is why it sits second in the treatment order.
Molnupiravir: The Last-Line Option
Molnupiravir (Lagevrio) is a third option used only when both Paxlovid and remdesivir are inaccessible or not clinically appropriate. It’s authorized for adults 18 and older at high risk for severe COVID-19. You take four capsules by mouth every 12 hours for five days, starting within five days of symptom onset.
It sits last in the treatment order because it is less effective. In its pivotal trial, molnupiravir reduced the risk of hospitalization or death by about 30% compared to placebo. Paxlovid’s benefit is considerably larger, which is why doctors reach for it first. Molnupiravir fills an important gap, though, particularly for patients on medications that make Paxlovid dangerous to use.
Over-the-Counter Symptom Relief
Whether or not you qualify for an antiviral, the basics of feeling better at home are the same. Acetaminophen (Tylenol) or ibuprofen (Advil, Motrin) can bring down fever and ease body aches, headache, and sore throat. Staying hydrated, resting, and using standard cold remedies for congestion and cough all apply just as they would for the flu.
These OTC treatments don’t fight the virus itself. They manage symptoms while your immune system does the work. For most people without risk factors for severe illness, this is the only treatment needed.
What About Monoclonal Antibodies?
Earlier in the pandemic, monoclonal antibody infusions were a major treatment option. That’s largely no longer the case. The virus has evolved enough that most of those earlier antibody therapies lost effectiveness against current variants and had their authorizations revoked.
One monoclonal antibody product, pemivibart (Pemgarda), has a limited authorization, but it’s not a treatment for active COVID-19. It’s a preventive option for people with moderate to severe immune compromise who can’t mount an adequate response to vaccination. It’s given before exposure to the virus, not after you’re already sick. For most people searching for what gets prescribed when they have COVID, monoclonal antibodies are no longer part of the picture.
How to Get a Prescription Quickly
Because the treatment window is narrow (ideally within the first five days of symptoms), speed matters more than with most prescriptions. If you test positive at home with a rapid test and you have any risk factors, call your primary care doctor, visit an urgent care clinic, or use a telehealth service the same day. Many telehealth platforms can prescribe Paxlovid after a brief virtual visit and send it to your pharmacy within hours.
Paxlovid is available at most retail pharmacies. Remdesivir requires an infusion setup, so your provider will need to arrange that at an outpatient clinic or infusion center. Molnupiravir is also dispensed at pharmacies but may be less widely stocked since it’s used less often.